N. Rozmaritsa

Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation

U. Ravens, T. Christ, A. Kaumann, 2014, Proceedings of the National Academy of Sciences.

Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

D. V. Van Wagoner, J. Stasch, K. Matschke, 2014, Cardiovascular research.

Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation

K. Matschke, D. Dobrev, N. Voigt, 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.

Ursula Ravens, Erich Wettwer, Torsten Christ, 2013, Cardiovascular research.

The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.

K. Matschke, D. Fedida, U. Ravens, 2013, Cardiovascular research.

NO-donors induce cross talk between cGMP and cAMP in signalling to human atrial L-type Ca2+ current

U. Ravens, E. Wettwer, T. Christ, 2011, BMC Pharmacology.